Ubs Group Ag Burning Rock Biotech LTD Transaction History

Ubs Group Ag

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.68 - $0.97 $56 - $80	83 New	83 $0
Q3 2023 Nov 09, 2023	BUY	$0.91 - $2.29 $1,569 - $3,950	1,725 New	1,725 $1,000
Q1 2023 May 12, 2023	BUY	$2.16 - $3.47 $2,248 - $3,612	1,041 Added 55.55%	2,915 $8,000
Q4 2022 Feb 08, 2023	BUY	$1.73 - $2.95 $3,242 - $5,528	1,874 New	1,874 $4,000
Q2 2022 Aug 10, 2022	BUY	$1.75 - $10.44 $51,138 - $305,077	29,222 Added 1169.82%	31,720 $93,000
Q1 2022 May 16, 2022	BUY	$6.7 - $10.23 $7,604 - $11,611	1,135 Added 83.27%	2,498 $23,000
Q4 2021 Feb 14, 2022	SELL	$9.43 - $17.14 $703,468 - $1.28 Million	-74,599 Reduced 98.21%	1,363 $13,000
Q3 2021 Nov 15, 2021	BUY	$17.37 - $27.92 $102,760 - $165,174	5,916 Added 8.45%	75,962 $1.36 Million
Q2 2021 Aug 13, 2021	BUY	$26.14 - $37.45 $1.83 Million - $2.62 Million	70,046 New	70,046 $2.06 Million
Q1 2021 May 12, 2021	SELL	$23.5 - $39.58 $9,635 - $16,227	-410 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$22.55 - $30.87 $9,245 - $12,656	410 New	410 $9,000
Q3 2020 Nov 12, 2020	SELL	$19.07 - $29.61 $62,644 - $97,268	-3,285 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$23.21 - $31.43 $76,244 - $103,247	3,285 New	3,285 $89,000

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $703M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.